Search results
Gilead Beats Earnings Expectations After Rocky Quarter
Barrons.com· 7 days agoGilead said that the charge had a $3.12 per share impact on the company’s diluted earnings. In an...
Gilead stock gains on revenue beat, despite a quarterly loss By Investing.com
Investing.com· 7 days agoGilead Sciences, Inc. (NASDAQ:GILD) has reported a revenue increase in its first quarter of 2024,...
UPDATE 1-Gilead posts quarterly loss on acquisition charge, revenue rises 5%
Reuters via Yahoo Finance· 7 days agoGilead's oncology sales rose 18% to $789 million. "We had a really strong quarter as reflected in both our commercial performance and clinical execution," Gilead CEO Daniel
Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 7 days agoThe press release, slides, and supplementary data are available on the Investors section of our...
Gilead's quarterly loss is narrower than expected
Morningstar· 7 days agoGilead Sciences Inc.'s stock dipped 0.2% in after-hours trading Thursday, after the drug company's adjusted first-quarter profit was narrower than expected. Gilead (GILD) posted a net loss of ...
Gilead Gives Up Big Gains As Covid Drug Drives Its Beat — Again
Investor's Business Daily· 6 days agoIn an interview with Investor's Business Daily, Gilead Chief Executive Daniel O'Day called the...
Q1 2024 Gilead Sciences Inc Earnings Call Transcript
Guru Focus· 7 days agoApr 25, 2024 / 08:30PM GMTOperator Good afternoon, everyone, and welcome to Gilead's First Quarter 2024 Earnings Conference Call. My name is Rebecca, and I'll b